A cross-sectional study to evaluate the effectiveness of XALKORI Patient Information Brochure among non-small cell lung cancer (NSCLC) patients receiving XALKORI treatment in Europe

First published 01/09/2014

Last updated 02/07/2024

EU PAS number:

EUPAS7393

Study

Finalised

Documents

Study protocol

Initial protocol

A8081050_PROTOCOL Crizotinib Patient Survey_25Mar2014

English (957.71 KB - PDF)View document

Updated protocol

A8081050_PROTOCOL AMENDMENT 2_Crizotinib Patient Survey_30 March 2015 Clean_Register

First published: 22/02/2024

English (354.13 KB - PDF)View document

Study results

Crizotinib A8081050 NI Study Report

English (4.33 MB - PDF)View document

Study report

Other information

Secondary tabs